Elizabeth Guelde
Psychiatric/Mental Health · Orlando, FLNPI 1811324585
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $32,139 of the $48,031 with a category attached, or 66.9%. Axsome Therapeutics, Inc. accounts for 64.5% of it on its own, with 15 other manufacturers making up the rest. 2025 is the largest year on record at $27,653, more than ten times the $215 reported in 2021. Among psychiatric/mental health clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 278 payments — averaging $172.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axsome Therapeutics, Inc.$31K
- AbbVie$14K
- Alkermes, Inc.$1K
- Teva Pharmaceuticals USA, Inc.$497
- Johnson & Johnson$344
- Vanda Pharmaceuticals Inc.$302
- plus $852 from 10 others
What the payments were for
- Consulting fees$5,25011%
- Speaking & faculty fees$32,13967%
- Travel & lodging$1,9634%
- Food & beverage$8,67918%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axsome Therapeutics, Inc. | 98 | $30,995 |
| AbbVie | 96 | $13,660 |
| Alkermes, Inc. | 35 | $1,381 |
| Teva Pharmaceuticals USA, Inc. | 9 | $497 |
| Johnson & Johnson | 7 | $344 |
| Vanda Pharmaceuticals Inc. | 4 | $302 |
| Tris Pharma Inc | 4 | $188 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $174 |
| Corium, LLC | 6 | $122 |
| E.r. Squibb & Sons, L.L.C. | 2 | $108 |
| Gilead | 1 | $100 |
| Bausch Health US, LLC | 4 | $68 |
| Neurocrine Biosciences, Inc. | 1 | $34 |
| Sunovion Pharmaceuticals Inc. | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auvelity$29,401
- VRAYLAR$11,968
- LYBALVI$1,337
- ARISTADA$411
- Fanapt$250
- AUSTEDO$231
- SPRAVATO$210
- Austedo XR$122
- Dyanavel XR$120
- VIVITROL$112
- UBRELVY$112
- ARISTADA INITIO$103
How this compares
$48,031 in reported general payments places this provider in the 95th percentile of 3,096 psychiatric/mental health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 12 | $81 |
| Alprazolam | 13 | $62 |
| Clonazepam | 12 | $41 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Orlando
- Amber SiegelOrlando$17K
- Orville MurrayOrlando$13K
- Roger RiveraKissimmee$1.6M
- Bethanie Simmons BecilJacksonville$782K
- Hannah PhillipsMaitland$455K
- Scott DurrancePensacola$224K
- Eudaldo AponteHialeah$214K
- Heather WarrenTallahassee$172K
- Angela DavenportAlachua$83K
- Natalie MoodyWinter Haven$75K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.